Skip to content
What if your smartwatch could spot infections before you even feel sick? Discover how wearable tech is revolutionizing early detection and fighting antimicrobial resistance for a healthier future.
Imagine a world where your smartwatch alerts you to an infection before you even feel unwell. This is becoming a tangible possibility as wearable technologies advance, offering continuous monitoring of physiological signals that could detect infections earlier than traditional methods. For laboratory managers, scientists, and healthcare professionals, this innovation promises a new frontier in managing infections and tackling antimicrobial resistance (AMR).
AMR is a looming global crisis. By 2050, drug-resistant infections could claim 10 million lives annually and cost the global economy $100 trillion. One challenge is that antibiotics are often prescribed before the infection’s cause is confirmed, leading to unnecessary use and accelerating resistance. Wearables could change this by providing early warning signs through continuous tracking of heart rate, respiratory rate, temperature, and sleep patterns, revealing subtle changes before symptoms appear.
During the COVID-19 pandemic, devices like Oura and Apple Watch demonstrated potential in detecting early viral illness signals. Now, clinical-grade wearables such as BioIntelliSense’s BioButton and Current Health’s upper-arm monitors are enabling remote patient monitoring, detecting deterioration sooner and supporting timely interventions. The next leap involves integrating biochemical sensors, inspired by continuous glucose monitors, to track infection markers or antibiotic levels in real time, offering precise treatment guidance.
This approach doesn’t replace laboratory diagnostics but complements them, triggering timely testing and refining antibiotic use to support antimicrobial stewardship. A hybrid pathway combining wearables with confirmatory tests and clinical review could revolutionize infection management, especially for vulnerable patients or those in remote care settings.
Parallel to technological advances, collaborative research efforts like those of the Mahidol Oxford Tropical Medicine Research Unit (MORU) highlight the power of integrating patient perspectives with clinical and laboratory expertise. MORU’s work across Asia, showcased during The Princess Royal’s visit to Thailand, has improved prevention and treatment of diseases including AMR-related infections, underscoring the importance of partnerships in global health.
Meanwhile, innovations in other medical fields, such as Good Hope Hospital’s milestone in conduction system pacing, demonstrate how aligning technology with natural physiology can improve patient outcomes. This technique helps the heart beat more naturally, reducing risks associated with traditional pacemakers.
For laboratory leaders and healthcare professionals, these developments signal a future where technology and collaboration drive smarter diagnostics and therapies. Embracing wearable technology and integrated research can enhance laboratory operations and patient care.
The fight against antimicrobial resistance demands innovation beyond the lab bench. Wearables and collaborative research are paving new paths. It’s time for healthcare professionals and laboratory leaders to engage with these emerging tools and shape the future of infection management.
